Latest filing published 27 Jul 2016 for Merrimack Pharmaceuticals INC, €96k.
Insider track record
Birgit M. Schoeberl: trading record in brief
All filings by Birgit M. Schoeberl on record concern Merrimack Pharmaceuticals Inc. Between 16 March 2015 and 25 July 2016, the trades on record add up to 9 filings.
Sales make up the whole of the open-market record (3 sales, €732k). Other entries cover 6 option exercises. 2016 to date brings no purchases and 1 sale.
On 27 July 2016 came the latest disclosure, an option exercise for €96k in Merrimack Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Birgit M. Schoeberl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$2.1227.8% of flowCommon StockSEC:0001209191-16-134106:0
- 50,000 shares@ US$5.5072.2% of flowCommon StockSEC:0001209191-16-134106:1
- 62,057 shares@ US$2.12Common StockSEC:0001179110-15-009536:0
- 20,000 shares@ US$1.71Common StockSEC:0001179110-15-005207:0
- 897 shares@ US$1.81Common StockSEC:0001179110-15-005207:1
- 20,897 shares@ US$12.00Common StockSEC:0001179110-15-005207:2
- 10,000 shares@ US$1.71Common StockSEC:0001179110-15-005207:3
- 11,337 shares@ US$1.81Common StockSEC:0001179110-15-005207:4
- 21,337 shares@ US$12.00Common StockSEC:0001179110-15-005207:5
9 of 9 declarations
